Jerzy Gumulka, Director at CNS Pharmaceuticals, Inc. (CNSP), bought 7,173 shares at $0.74 ($5K) on 2023-04-10, disclosed to the SEC on 2023-04-17.
Open-market purchase of $5k CNSP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |